conclusions cd5l might be a useful biomarker for early diagnosis of hcc in hcv cirrhotic patients. lrg and hp α2 isoforms could be potential markers for distinguishing viral hcc. our results also further support the presence of varying molecules involved in hepatocarcinogenesis in hbv when compared with hcv infection. patients and methods two-dimensional polyacrylamide gel electrophoresis combi...

Abstract Fatty acid-binding protein 5 (FABP5) is highly expressed in hepatocellular carcinoma (HCC) tissues and related to HCC progression. In this study, we analyzed the potential of serum FABP5 (sFABP5) as a tumor marker its clinical significance We compared sFABP5 concentration patients with (HCC group) that hepatitis without (hepatitis group). Moreover, measured expression levels resected (...

Contrast-enhanced ultrasound (CEUS) and super-resolution (US) are novel technologies for differentiating hepatic masses including hepatocellular carcinoma (HCC). Kupffer-phase imaging on Sonazoid CEUS can increase the diagnostic sensitivity HCC, facilitates early identification treatment of HCC. On other hand, US depict intratumoral vascularity without contrast enhancement, its performance iden...

Background: Hepatocellular carcinoma (HCC) is a common malignant tumor with 5-year survival rate of 10%, presenting extrahepatic metastases in 15–17% patients. HCC-bone represent approximately one-quarter all HCC metastases, most frequently the spine, pelvis, ribs, or femur. HCC-skull however, make up 0.4–1.6% HCC- bone metastases. Furthermore, solitary metastasis without known active primary a...

In September 2001, during follow-up at our outpatient liver unit we detected by ultrasound a hypervascular mass adjacent to the VI hepatic segment in a 78-year-old HCV-positive cirrhotic woman. Subsequently abdominal computed tomography (CT) revealed an infiltrative vascularized nodule (3.5 cm in diameter) at the lower border of the VI hepatic segment and magnetic resonance imaging showed a “te...

Hepatocellular cancer (hcc) is the 2nd most frequent cause of cancer-related death in men and the 6th in women1. In 2008, the number of new liver cancer cases was estimated to be 748,300 worldwide, and 695,900 deaths were attributed to liver cancer that same year1. Overall, liver transplantation, surgical resection, and locoregional therapies are the treatment options for hcc. However, only a s...